Every intervention Outliyr has scored for more energy, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for more energy; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
84 of 137 evaluated interventions score 3.0+ out of 10 for more energy · 21 comparisons
The practical energy read on Electrolytes is 7.5/10 because Borra 2025 anchors the strongest signal. The existing rationale points to this narrower claim: Dehydration-related fatigue can correct quickly with water and electrolytes.…
Read the Electrolytes report →Creatine Monohydrate is a 7.0/10 energy fit because Watanabe 2002 reports Cognitive performance under mental load and sleep deprivation. The score stays conditional because Creatine Monohydrate still needs better outcome data for…
Read the Creatine Monohydrate report →Magnesium energy earns 7.0/10 because de Baaij 2015 anchors the most relevant signal. Magnesium fits energy when low intake, stress load, mineral loss, or a form-specific target makes deficiency correction plausible. The…
Read the Magnesium report →Energy gets 7.0/10 because Red Light Therapy acts on mitochondrial photobiology, with Karu 2010 supporting ATP-related mechanisms at cytochrome c oxidase. The human outcome is more variable than the mechanism. Low-baseline users,…
Read the Red Light Therapy report →Mechanistically, Modafinil scores 7.0/10 for energy because the evidence points to a plausible use case without proving a universal response. Mann G et al. 2026 is the best anchor here because it…
Read the Modafinil report →The practical energy read on TRT (Testosterone Replacement Therapy) is 7.0/10 because Lincoff 2023 reports TRAVERSE cardiovascular outcomes trial in 5,246 hypogonadal men with cardiovascular risk; major cardiovascular events non-inferior, with monitoring-relevant…
Read the TRT (Testosterone Replacement Therapy) report →Ephedrine earns 7.0/10 for energy; this is a targeted fit score. Reliable acute stimulation via direct + indirect adrenergic activation; Tmax 1.8 hours, peak effect 1-2 hours. Tachyphylaxis develops within 2-4 weeks…
Read the Ephedrine report →On energy, Methylene Blue deserves 6.8/10 because Rodriguez 2016 makes the claim plausible but incomplete. The existing rationale points to this narrower claim: Subjective energy is a consistent user report and fits…
Read the Methylene Blue report →A 6.5/10 for energy fits Zone 2 Cardio because Kodama 2009 supports direction more than certainty. The existing rationale points to this narrower claim: Daytime energy is a common downstream benefit as…
Read the Zone 2 Cardio report →The practical energy read on Molecular Hydrogen is 6.5/10 because Dhillon 2024 reports 25-article systematic review; mixed preliminary clinical evidence, heterogeneity, and need for stronger trials. Zhou 2024 points in the same…
Read the Molecular Hydrogen report →Shilajit energy earns 6.5/10 because Pandit 2016 anchors the most relevant signal. Shilajit fits energy when purified resin is matched to hormones, sperm parameters, strength fatigue, bone markers, or energy tracking. The…
Read the Shilajit report →Fatigue and asthenia are the best-supported clinical use case for Bromantane. The Voznesenskaia 2010 multicenter trial in 728 outpatients with asthenic syndrome reported a CGI-I responder rate of 90.8% at 50 to…
Read the Bromantane (Ladasten) report →Paraxanthine scores 6.2/10 for energy because the most plausible benefit is acute perceived energy or stimulant-like activation. The strongest support comes from Yoo C. et al. 2021, but the practical rating stays…
Read the Paraxanthine (Enfinity) report →A Cochrane review of nine trials (7,111 participants) reports that Tirzepatide produces roughly a 10% body-weight reduction versus placebo, which is the primary driver of any perceived boost in energy Franco 2025.…
Read the Tirzepatide report →Energy is a secondary Norwegian 4x4 use case, scoring 6.0/10 because the original trial reported a clear VO2max gain after six weeks Helgerud 2007. Better aerobic capacity can make daily tasks feel…
Read the Norwegian 4×4 report →Neurofeedback earns 6.0/10 in energy because Marzbani et al. 2016 supports the main pathway. Energy effects are secondary. Users may feel more mentally clear when attention, sleep, and arousal regulation improve, but…
Read the Neurofeedback report →Energy lands at 6.0/10, real for deficit states but oversold for healthy people. CoQ10's role in ATP synthesis makes restored energy plausible where levels are low, such as statin users, older adults,…
Read the Coenzyme Q10 (CoQ10 / Ubiquinol) report →On energy, Tongkat Ali deserves 6.0/10 because Tambi 2012 makes the claim plausible but incomplete. The existing rationale points to this narrower claim: Energy claims are mostly downstream of stress, mood, and…
Read the Tongkat Ali report →Energy scores 6.0/10. Higher aerobic capacity from SIT, shown as a rapid VO2max gain in Gist 2014 and a near-doubling of endurance capacity in Burgomaster 2005, makes daily tasks feel easier over…
Read the Sprinting (Sprint Interval Training) report →Population fit explains the 5.8/10 energy score for Time-Restricted Eating because the evidence points to a plausible use case without proving a universal response. Sun Y et al. 2025 is the best…
Read the Time-Restricted Eating report →Essential Amino Acids earns 5.5/10 for energy because Hagiyama 2024 reports 12 RCTs; 622 patients; low-certainty improvement in patient-reported outcomes and very-low-certainty strength signal after lower-limb surgeries. Wittholz 2024 points in the…
Read the Essential Amino Acids report →Glycine energy earns 5.5/10 because Soh 2024 anchors the most relevant signal. Glycine fits energy because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the endpoint. The…
Read the Glycine report →The energy evidence puts Vagus Nerve Stimulation at 5.5/10, helped by Zhang et al. 2026. Energy benefits are mostly indirect through better sleep and lower sympathetic load; no strong direct energy endpoint…
Read the Vagus Nerve Stimulation report →Peng et al. 2024 reported a 7 % increase in concentric knee extensor torque after a single Whole-Body Vibration session, suggesting an acute boost in muscular power. Whole-Body Vibration is scored 5.5/10…
Read the Whole-Body Vibration report →The main limitation behind Ketogenic Diet's 5.5/10 energy score is that the evidence points to a plausible use case without proving a universal response. Leung GKW et al. 2025 is the best…
Read the Ketogenic Diet report →Senolytics gets 5.5/10 for energy, with Chaib et al. 2022 giving the cleanest evidence anchor. Reduced SASP inflammation may improve subjective energy in older or inflamed users, but human F+Q energy outcomes…
Read the Senolytics report →NMN energy earns 5.5/10 because Wang 2024 anchors the most relevant signal. NMN fits energy when raising NAD+ is likely to matter for older, metabolically stressed, or performance-tracking users. The score stays…
Read the NMN (Nicotinamide Mononucleotide) report →Dynamine scores 5.5/10 for energy because the most plausible benefit is acute perceived energy or stimulant-like activation. The strongest support comes from Cintineo H. et al. 2022, but the practical rating stays…
Read the Dynamine (Methylliberine) report →The evidence for SLU-PP-332's impact on energy is limited to a single mouse study that reported a 12% increase in treadmill endurance and was documented by Billon et al. 2023. The proposed…
Read the SLU-PP-332 report →A 5.4/10 for energy fits Ca-AKG (Calcium Alpha-Ketoglutarate) because Shahmirzadi 2020 supports direction more than certainty. The existing rationale points to this narrower claim: Mechanistic energy-metabolism rationale exists, and Nick notes subjective…
Read the Ca-AKG (Calcium Alpha-Ketoglutarate) report →Phenylpiracetam scores 5.3/10 for energy because the most plausible benefit is acute perceived energy or stimulant-like activation. The strongest support comes from Malykh A. et al. 2010, but the practical rating stays…
Read the Phenylpiracetam (Phenotropil) report →For energy, the 5.0/10 score reflects how HRV Biofeedback performs in Rosendo da Cunha e Silva et al. 2026. Reduced fatigue as secondary outcome across multiple anxiety/depression studies. The score stays bounded…
Read the HRV Biofeedback report →Energy scores 5.0/10 because fatigue is one of the earliest and most reversible symptoms of vitamin C deficiency. Genuinely low people, including smokers and those with poor diets, often report meaningful energy…
Read the Vitamin C (Ascorbic Acid) report →Energy and fatigue scores 5.0/10 on small exercise trials. Kalafati 2010 used a double-blind crossover in 9 trained men at 6 g/day for 4 weeks and found time to fatigue rising from…
Read the Spirulina report →Rapamycin energy earns 5.0/10 because Harrison 2009 anchors the most relevant signal. Rapamycin fits energy when mTORC1 modulation, autophagy, immune aging, or senescence biology is the actual target. The score stays bounded…
Read the Rapamycin report →Energy and fatigue score 5.0/10 on indirect but plausible grounds. Improved mitochondrial fuel oxidation and lower oxidative stress are energy-relevant, and older participants reported better physical function, but there is no dedicated…
Read the GlyNAC (Glycine + N-Acetylcysteine) report →MOTS-c fits energy at 5.0/10 when the baseline problem is real. MOTS-c earns an energy score from exercise-mimetic AMPK activation, Reynolds 2021 exercise biology, and Nick's subjective energy response. Human energy endpoints…
Read the MOTS-c report →Oxiracetam scores 5.0/10 for energy because the most plausible benefit is acute perceived energy or stimulant-like activation. The strongest support comes from Copani A. et al. 1992, but the practical rating stays…
Read the Oxiracetam report →Energy scores 5.0/10 because Semaglutide can improve fatigue tied to obesity and glucose swings, but it can also cause fatigue through low intake, dehydration, nausea, or rapid weight loss. Wilding 2021 supports…
Read the Semaglutide report →Mixed and individual. Some users report a clean acute energy and focus lift from the rapid fuel shift, since the brain and muscle readily use BHB as a substrate; others feel GI-driven…
Read the Exogenous Ketones report →Daytime energy and reduced tiredness are among the more believable felt effects of this class. The human support is the Tang 2005 reishi trial, where neurasthenia patients reported a 28.3 percent drop…
Read the Adaptogenic Mushrooms (Reishi, Cordyceps, Chaga) report →Some users report energy improvements after full protocols, especially with fatigue syndromes, but Kjellberg 2025 weakens short-course long-COVID fatigue expectations.
Read the Hyperbaric Oxygen Therapy report →Improved functional capacity can raise perceived energy over time, but BFR is not an acute energy intervention.
Read the Blood-Flow Restriction Training report →Some users report energy lift and exercise-efficiency reviews are directionally positive, but astaxanthin is not an acute stimulant.
Read the Astaxanthin report →Energy scores 4.5/10. Many users report a refreshed, energized feeling after a session and the cooling rebound, but sauna is not a stimulant and there is no objective energy or fatigue trial…
Read the Traditional Sauna (Finnish Dry-Heat) report →Better muscle function can translate to better daily energy, especially in deconditioned users. Evidence is indirect from strength and function outcomes rather than EMS-specific fatigue trials, so the score remains moderate.
Read the Full-Body EMS report →Energy is a mixed 4.5. Regular aerobic conditioning typically improves daytime stamina and reduces fatigue over weeks, but rucking is also a genuine energy cost in the session and can drain you…
Read the Rucking (Weighted Walking) report →T2D users may feel more energy when glucose normalizes, while healthy users can experience fatigue or training-output tradeoffs. The direct energy score stays below neutral.
Read the Metformin report →Some users report steadier energy on chlorella, plausibly from correcting iron, B-vitamin, or general micronutrient gaps, but there is no controlled human evidence that it raises energy as a primary effect. It…
Read the Chlorella report →Energy and fatigue score 4.5/10 on subjective and indirect grounds. People with high oxidative-stress burden sometimes report better energy when glutathione status improves, and fatigue is the most common positive anecdote, but…
Read the Glutathione (GSH) report →NAD+ is essential for cellular energy metabolism, but most healthy adults report no obvious subjective energy effect despite biochemical elevation.
Read the NR (Nicotinamide Riboside) report →Restoring ETC efficiency should improve cellular energy production, but Nick's N=1 was neutral and Karaa 2023 did not confirm broad PMM fatigue benefit.
Read the SS-31 (Elamipretide) report →C60 energy scoring stays at 4.5 because anecdotal energy reports are common but uncontrolled. Longecity users describe stamina shifts, yet placebo contribution and responder bias are large. The proposed mitochondrial mechanism has…
Read the C60 (Buckminsterfullerene) report →Acute mental energy is one of the more common community-reported benefits, but no formal fatigue, vitality, or mental-energy endpoint trial verifies the effect.
Read the Semax report →Not a stimulant. Any fatigue benefit would be slow and antioxidant-mediated; no dedicated energy or fatigue trial supports a meaningful effect.
Read the Ergothioneine report →Mitochondrial biomarker changes can translate into energy for some low-baseline users, but subjective energy reports are mixed and not a proven acute effect.
Read the Urolithin A report →Improved VAT, sleep quality, and metabolic markers may improve subjective energy in selected users. Tesamorelin has no stimulant mechanism, and energy outcomes were not primary endpoints in the pivotal evidence.
Read the Tesamorelin report →Some users report a hydration or energy lift, but there is no controlled trial of Quinton for fatigue, and the mineral dose per ampoule is modest.
Read the Quinton Marine Plasma (Seawater Minerals) report →Energy and anti-fatigue use scores 4.0 out of 10, resting on traditional tonic use and the broad nutrient profile rather than human trials. Pine pollen supplies amino acids, B vitamins, and minerals,…
Read the Pine Pollen report →Community reports improved energy and vitality; GH elevation can feel energizing, but this is not verified by controlled CJC-1295 outcome trials.
Read the CJC-1295 report →Energy gains are an indirect downstream of better tissue repair, recovery, and inflammation control, not a direct Tβ4 mechanism. No trial has measured energy or fatigue endpoints.
Read the Thymosin Beta-4 (Tβ4) report →Some users report a subtle lift tied to better oxidative balance, but NAC is not a stimulant and has no direct energy or fatigue RCT base in healthy people.
Read the NAC (N-Acetylcysteine) report →Indirect via mitochondrial quality control; no subjective-energy RCT.
Read the Spermidine report →Indirect via reduced inflammation and improved tissue function. Energy claims are secondary and should be interpreted as feeling better after an injury heals, not direct mitochondrial stimulation.
Read the BPC-157 report →Energy effects are indirect through mood, sleep, gut-brain, and inflammation pathways. Lion's Mane is not a primary energy compound and should not be positioned like caffeine or creatine.
Read the Lion’s Mane report →Energy effects are restorative rather than stimulating. Users with poor sleep, elevated stress, or burnout-like physiology may feel more stable energy after stress improves. Low-stress users may feel sedated or blunted instead,…
Read the Ashwagandha report →Fatigue improved in some cancer-support studies and not others; not an acute energy agent.
Read the Fucoidan (Brown Seaweed Polysaccharide) report →Acute energy lift from sustained catecholamine elevation is one of the most reliable subjective effects in the cold-plunge corpus. Sramek 2000 documented the magnitude (NE +530 percent, DA +250 percent at 14…
Read the Cold Plunge report →Energy is the most-reported subjective effect, and Nick feels it within 30 minutes, but no trial has measured it. The plausible route is restored NAD+ supporting cellular energy production.
Read the 5-Amino-1MQ report →Neither direct human RCT established a reliable subjective energy or objective fatigue benefit at 200 mg/day. Robinson 2024 (Robinson 2024) was designed around overweight and obesity biomarkers, while Chooi 2024 TANGO focused…
Read the C15 (Pentadecanoic Acid) report →Energy has no direct saffron RCT endpoint; any lift is indirect through better mood, lower perceived stress, and better sleep quality.
Read the Saffron report →Indirect via caffeine optimization. L-theanine is not a primary energy intervention and may feel flattening in already-calm users.
Read the L-Theanine report →Energy scores 3.0/10. Any acute lift from coffee or tea is caffeine, not the polyphenols.
Read the Polyphenols (Dietary) report →Energy remains a 3 because mitochondrial and repair-gene claims are indirect. No human fatigue, ATP, or performance endpoint trial supports GHK-Cu for energy. Pickart 2018 is the review-level background.
Read the GHK-Cu report →Some users report better energy during illness, but no objective fatigue or energy endpoint is established. Effects likely reflect recovery from immune suppression rather than stimulant-like energy.
Read the Thymosin Alpha-1 report →Russian clinical reports describe antiasthenic effects, and anxiety reduction often improves perceived energy. There is no fatigue-specific RCT.
Read the Selank report →Energy may improve when glucose volatility improves, but berberine is not an energizing supplement for healthy users. Complex I inhibition makes fatigue a plausible issue in some.
Read the Berberine report →Energy benefits are indirect through fewer illness days or less gut stress during training. Bovine colostrum is not an acute energy substrate, stimulant, or mitochondrial enhancer.
Read the Colostrum report →Quality-of-life improvements in Russian elderly peptide literature included energy and vitality-like outcomes, but objective energy-metabolism endpoints are absent. Any energy effect is likely secondary to sleep or circadian rhythm rather than direct…
Read the Epitalon report →Some people report steadier energy from lower inflammation, but no direct fatigue trials support this as a primary use.
Read the Curcumin report →Some people report steadier energy as gut inflammation settles, but no direct fatigue trials support this. Indirect at best.
Read the Sodium Butyrate report →Glucagon is thermogenic and weight loss can improve daily energy in metabolic disease, but nausea and sustained caloric deficit can reduce energy. Retatrutide has no direct fatigue or vitality endpoint.
Read the Retatrutide report →Energy is the headline marketed claim and the most common same-session report after IV NAD+, but it rests on subjective drip-feel rather than controlled measurement. The one human study is pharmacokinetic, not…
Read the NAD+ (Direct) report →Energy and alertness are a side consequence of the stimulant-class mechanism, not a clean benefit. Raising central noradrenaline and dopamine produces a wakeful, appetite-suppressed state, and the modest rise in energy expenditure,…
Read the Tesofensine report →Nothing matches those filters.
Head-to-head reports and category rankings that name a winner on this use case.
Tirzepatide, at 6.1, then semaglutide at 6.0, then orforglipron at 5.8 if you want the pill. All three are approved, all three have real trial evidence, and all…
Ca-AKG, urolithin A and MOTS-c tie at 6.5, and only the first two are things you can legally buy. SS-31 follows at 6.0. The bottom three score low…
Tesamorelin, at 6.2, and only if you have a clinical reason. Every one of the nine scores 6.2 or lower, so the category tops out at worth trying…
Bromantane and semax tie at 7.1, and they are the only two in this category scored strong recommend. Selank is third at 6.9 if anxiety rather than focus…
Shilajit at 7.4, phosphatidylserine at 7.3, tongkat ali at 7.0. TRT ranks seventh at 5.7 and wins nine of the eleven use cases outright. That inversion is the…
Neither, if fat loss is the goal. Both score 2.0 on body composition, which is the row a vendor sells them on. AOD-9604 scores 4.6 overall and its…
Bromantane, for anything you plan to repeat. It scores 7.1 against phenylpiracetam's 5.5 and wins every shared use case that is not a floor tie: energy 6.2 to…
CoQ10 scores 7.1 and methylene blue 6.1, yet methylene blue wins eleven of the seventeen shared use cases. The overall gap is risk, not effect. Methylene blue inhibits…
The scores tie at 6.3 and 6.4 and every shared subrating sits within half a point, so the numbers decide nothing. Access and evidence decide it. Gonadorelin is…
Kisspeptin-10 scores 6.4 and TRT 5.7, and TRT still wins 13 of the 15 use cases both reports score. The higher number reflects dependency and reversibility, not effect.…
They solve different problems and the scores hide that. Oxytocin scores 6.5 against PT-141's 5.4, mostly on safety and cost. PT-141 still wins libido 5.5 against 2.5. Oxytocin…
Shilajit scores 7.4 and ashwagandha 6.8, but that gap is the least useful number here. These two do different jobs. Shilajit is the mineral and androgen play: male…
Electrolytes, at 7.5 out of 10 for more energy. The practical energy read on Electrolytes is 7.5/10 because Borra 2025 anchors the strongest signal.
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 5.5 out of 10 for more energy.
84 of the 137 interventions evaluated for more energy score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
